Drugs by condition
Drugs approved for chronic hives (urticaria)
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
13
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
3
New molecular entities and new biologics
In development
18
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for chronic hives (urticaria).
- Omlyclo (Omalizumab-Igec) · Celltrion INC Mar 7, 2025
- Quzyttir (Cetirizine Hydrochloride) · Esteve Oct 4, 2019
- Dupixent (Dupilumab) · Regeneron Pharmaceuticals NovelBreakthrough therapyPriority reviewOrphanMar 28, 2017
- Epinephrine (Epinephrine) · Bpi Labs Jul 29, 2014
- Adrenalin (Epinephrine) · Ph Health Dec 18, 2013
All approved drugs for chronic hives (urticaria), by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 105 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
alpha-Adrenergic Agonist (6)
- Epinephrine Epinephrine · Bpi Labs · 2014
- Adrenalin Epinephrine · Ph Health · 2013
- Adrenalin Epinephrine · Ph Health · 2012
- Auvi-Q Epinephrine · Kaleo INC · 2012
- Adrenaclick Epinephrine · Impax · 2003
- Epipen E Z Pen Epinephrine · Viatris · 1987
Anti-IgE (2)
Interleukin-4 Receptor alpha Antagonist (1)
- Dupixent Dupilumab · Regeneron Pharmaceuticals · 2017
Histamine-1 Receptor Antagonist (1)
- Clarinex Desloratadine · Organon · 2001
Class not listed in FDA's data (3)
- Quzyttir Cetirizine Hydrochloride · Esteve · 2019
- Karbinal Er Carbinoxamine Maleate · Aytu · 2013
- Gastrocrom Cromolyn Sodium · Viatris Specialty · 1996
Drugs in development for chronic hives (urticaria)
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- PovorcitinibINCB054707, INCB54707Phase 312 trials
Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis
- CM512Phase 39 trials
Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma
- LP-003SinglePhase 39 trials
Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies
- TLL-018Phase 38 trials
Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria
- barzolvolimabCDX-0159Phase 37 trials
Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria
- MG-K10Humanized Monoclonal AntibodyPhase 36 trials
Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis
- JYB1904RPT904, ozureprubartPhase 35 trials
Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases
- ICP-332Phase 34 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis
- MG-K10 Humanized Monoclonal AntibodyPhase 34 trials
Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)
- AK139Phase 26 trials
Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria
- EVO756Phase 24 trials
Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis
- BLU-808Phase 22 trials
Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis
- BBT001Phase 21 trial
Bambusa Therapeutics · Chronic Spontaneous Urticaria
- BriquilimabJSP191Phase 21 trial
Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria
- HRS-3095Phase 21 trial
Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria
- HS-10561Phase 21 trial
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria
- LesigerceptPhase 21 trial
Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)
- NN2802Phase 21 trial
Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)
1 discontinued brand-name drugs whose label still names it
- Xyzal Levocetirizine Dihydrochloride
More on chronic hives (urticaria): recruiting trials · published research
Related in immunology and inflammation: Rheumatoid arthritis · Plaque psoriasis · Psoriatic arthritis · Atopic dermatitis (eczema) · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Lupus (SLE) · Hidradenitis suppurativa · Alopecia areata
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.